Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)
Clinical trial NCT03777085 · UNKNOWN
Trial details
- NCT number
- NCT03777085
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-10
- Primary completion
- 2020-12-30
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.